Cibula, D., Rob, L., Mallmann, P., Knapp, P., Klat, J., Chovanec, J., Minář, L., Melichar, B., Hein, A., Kieszko, D., Pluta, M., Špaček, J., Bartoš, P., Wimberger, P., Madry, R., Markowska, J., Streb, J., Valha, P., Bin Hassan, H. I., Pecen, L., Galluzzi, L., Fučíková, J., Hrnčiarová, T., Hraška, M., Bartůňková, J., Spíšek, R. Dendritic Cell-based Immunotherapy (DCVAC/OvCa) Combined with Second-line Chemotherapy in Platinum-sensitive Ovarian Cancer (SOV02): A Randomized, Open-label, Phase 2 Trial. Gynecologic Oncology. 2021, 162(3), 652-660. ISSN 0090-8258. E-ISSN 1095-6859. Dostupné z: https://doi.org/10.1016/j.ygyno.2021.07.003.